Comparison of anticancer effects of a novel histone deacetylase (HDAC) inhibitor CG200745 and SAHA in non-small lung cancer cells

被引：0
|
作者：
Kim, Hak-Ryul [1 ]
Jung, Jae-Wan [1 ]
Hwang, Ki-Eun [1 ]
Park, Chul [1 ]
Jeong, Eun-Taik [1 ]
机构：
[1] Wonwang Univ Hosp, Iksan, South Korea
来源：
EUROPEAN RESPIRATORY JOURNAL | 2019年 / 54卷
关键词：
Lung cancer; Experimental approaches;
D O I：
10.1183/13993003.congress-2019.OA1911
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
OA1911
引用
收藏
页数：2
相关论文
共 50 条
  • [21] The histone deacetylase inhibitor, vorinostat, increases carboplatin and paclitaxel activity in non-small cell lung cancer cells.
    Owonikoko, Taofeek
    Ramalingam, Suresh
    Kanterewicz, Beatriz
    Balius, Trent
    Belani, Chandra
    Hershberger, Pamela
    CANCER RESEARCH, 2009, 69
  • [22] Silibinin synergizes with histone deacetylase (HDAC) inhibitors in upregulating E-cadherin expression in non-small lung cancer (NSCLC) cells
    Mateen, Samiha
    Raina, Komal
    Agarwal, Chapla
    Chan, Daniel
    Agarwal, Rajesh
    CANCER RESEARCH, 2012, 72
  • [23] HDAC Inhibitor, CG-745 Inhibit EMT and Induce Apoptosis in Non-small Cell Lung Cancer
    Kim, Hak-Ryul
    Hwang, Ki-Eun
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [24] Combined Effects of HDAC Inhibitor and Metalloproteinase Inhibitor on Invasion and Growth of Non-Small Cell Lung Cancer
    Zhang, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (11) : S1142 - S1142
  • [25] Histone deacetylase inhibitor; CG005, is a novel anticancer drug; as a combination drug with docetaxel in prostate cancer
    Kim, Yong Sook
    Kim, Mi Joung
    Choi, Jene
    Jang, Sejin
    Lee, Je-hwan
    Ro, Seonggu
    Kim, Choung-soo
    Hwang, Jung Jin
    CANCER RESEARCH, 2011, 71
  • [26] Anticancer activity of a novel histone deacetylase inhibitor against human colorectal cancer cells
    Campostrini, N.
    Cecconi, D.
    Mill, A.
    Vindigni, A.
    Bossi, A.
    Righetti, P. G.
    MOLECULAR & CELLULAR PROTEOMICS, 2006, 5 (10) : S97 - S97
  • [27] Combined proteasome and histone deacetylase inhibition in non-small cell lung cancer
    Denlinger, CE
    Keller, MD
    Mayo, MW
    Broad, RM
    Jones, DR
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2004, 127 (04): : 1078 - 1086
  • [28] Histone Deacetylase Inhibition in Non-small Cell Lung Cancer: Hype or Hope?
    Mamdani, Hirva
    Jalal, Shadia, I
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [29] Antitumor effects of a novel histone deacetylase inhibitor NK-HDAC-1 on breast cancer
    Li, Zhong-Hua
    Zhang, Xiao-Bing
    Han, Xi-Qian
    Feng, Cong-Ran
    Wang, Feng-Shan
    Wang, Peng George
    Shen, Jie
    Shi, Yi-Kang
    ONCOLOGY REPORTS, 2013, 30 (01) : 499 - 505
  • [30] A novel and oral histone deacetylase inhibitor, resminostat, effectively suppresses the growth of non-small cell lung cancer in a xenograft mouse model
    Takagi, Akimitsu
    Konishi, Hiroaki
    Tsugane, Momomi
    Taniguchi, Keisuke
    Takahashi, Hiroyuki
    Inutake, Yu
    Watanabe, Akinobu
    Kodaira, Hiroshi
    Matsuzaki, Takeshi
    CANCER RESEARCH, 2014, 74 (19)
12345